Pembrolizumab in PMBCL, allogeneic CD19 CAR T cells for pediatric B-cell ALL, and fetal iron overload in β-thalassemia
Blood Podcast
00:00
The Role of Checkpoint Inhibitors in PMBCL
Long-term follow-up data suggest that some patients may be cured with immune checkpoint blockade alone. The safety profile is reassuring, but larger studies are needed to flesh out the AEE profile. Allogenaic Donor Derived 2nd Generation CD19 CAR T-cells for the treatment of pediatric relapsed refractory BCP-AL.
Transcript
Play full episode
